Skip to main
IQV

IQVIA Hlds (IQV) Stock Forecast & Price Target

IQVIA Hlds (IQV) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 40%
Buy 53%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

IQVIA Holdings demonstrates significant positive momentum in its operations, with year-over-year growth reported in its Functional Service Provider (FSP), Real World Evidence (RWE), and Commercial Services and Medical Solutions (CSMS) segments during the third quarter. The company has improved client decision timelines and maintains a strong pipeline, which bodes well for its commercial solutions segment, particularly driven by recent drug launches. Furthermore, IQVIA anticipates a growth rate exceeding 4% in its Research and Development Solutions segment on a constant currency basis, supported by an improved pricing environment that allows the company to selectively engage in high-value deals.

Bears say

The financial outlook for IQVIA Holdings reflects a decline in year-over-year constant currency growth, decreasing to 3.8% from 6.8% in the previous period, attributed to challenging year-over-year comparisons and a specific growth figure of 8.6% from the earlier year. Despite assurances from the company that it does not foresee a regression in revenue growth for 2026, there are concerns about its ability to maintain positive growth levels, with expectations set at a minimum of 5% growth. Additionally, operational issues such as zero margin passthroughs and the potential negative impact of rising interest rates on earnings further exacerbate uncertainties surrounding the company's financial performance.

IQVIA Hlds (IQV) has been analyzed by 15 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 53% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IQVIA Hlds (IQV) Forecast

Analysts have given IQVIA Hlds (IQV) a Buy based on their latest research and market trends.

According to 15 analysts, IQVIA Hlds (IQV) has a Buy consensus rating as of Apr 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $234.13, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $234.13, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IQVIA Hlds (IQV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.